Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Anxo Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,106	1,336	2,708	1,426	1,185	1,376
Market Cap Growth	-18.21%	-50.67%	89.95%	20.32%	-13.90%	-3.90%
Enterprise Value	1,627	1,837	3,497	2,194	1,989	2,164
Last Close Price	19.80	24.00	48.11	28.23	23.46	27.25
PE Ratio	-	-	123.88	-	61.60	43.82
PS Ratio	1.25	1.49	2.88	1.65	1.44	1.59
PB Ratio	0.99	1.17	2.25	1.72	1.42	1.70
P/TBV Ratio	1.15	1.37	2.58	2.09	1.71	2.05
P/FCF Ratio	38.57	19.18	-	25.16	27.23	31.35
P/OCF Ratio	16.80	11.93	-	20.00	15.12	22.98
EV/Sales Ratio	1.84	2.05	3.72	2.53	2.41	2.50
EV/EBITDA Ratio	60.01	448.02	30.92	32.01	19.10	17.14
EV/EBIT Ratio	-	-	65.59	368.98	49.61	37.97
EV/FCF Ratio	56.72	26.38	-	38.71	45.73	49.29
Debt / Equity Ratio	0.64	0.64	0.66	1.07	1.06	1.10
Debt / EBITDA Ratio	26.51	38.13	6.21	11.18	7.74	6.52
Debt / FCF Ratio	25.06	10.44	-	15.65	20.28	20.25
Asset Turnover	0.42	0.41	0.45	0.45	0.43	0.45
Inventory Turnover	2.02	2.09	2.06	2.22	1.95	2.13
Quick Ratio	1.06	1.15	1.33	0.89	0.92	0.88
Current Ratio	1.68	1.75	2.01	1.39	1.49	1.51
Return on Equity (ROE)	-3.79%	-4.62%	3.03%	-0.85%	2.40%	5.15%
Return on Assets (ROA)	-1.42%	-1.64%	1.59%	0.19%	1.31%	1.86%
Return on Invested Capital (ROIC)	-3.15%	-3.64%	2.76%	0.40%	2.17%	3.01%
Return on Capital Employed (ROCE)	-3.10%	-3.50%	3.10%	0.40%	2.80%	3.90%
Earnings Yield	-3.83%	-4.28%	0.81%	-0.88%	1.62%	2.28%
FCF Yield	2.59%	5.21%	-2.23%	3.98%	3.67%	3.19%
Dividend Yield	2.01%	-	0.83%	-	-	-
Payout Ratio	-	-	-	-	-	36.52%
Buyback Yield / Dilution	-2.25%	-8.00%	-7.11%	0.66%	-0.88%	-7.05%
Total Shareholder Return	-0.26%	-8.00%	-6.28%	0.66%	-0.88%	-7.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.